
Emerging SME Services · NSE
Incorporated in October 1971, Vijaypd Ceutical Limited is a pharmaceutical distributor that supplies a wide range of pharmaceutical products and consumer goods while offering comprehensive services. The company operates in various capacities, including as representatives, dealers, agents, stockists, suppliers, traders, and packers. It caters to the pharmaceutical, wellness, and FMCG sectors, offering a diverse portfolio that includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products. Additionally, the company supplies vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items like soaps, sanitizers, and baby care products, as well as ayurvedic products, cosmetics, food items, dental products, and crude drugs. As of March 31, 2025, Vijaypd Ceutical Limited serves over 2,109 pharmacies, clinics, and nursing homes across four districts, spanning 20 locations. Its extensive distribution network connects with more than 170 healthcare product manufacturers, offering access to over 19,000 stock-keeping units (SKUs). This wide-ranging portfolio enables the company to effectively meet customer needs while maintaining high standards of quality and reliability in pharmaceutical supply. The company holds certifications from the FDA, FSSAI, and BMC, underscoring its commitment to regulatory compliance and quality assurance.
Price Band
₹35
Issue Size
₹19.25 Cr
Lot Size
4000 shares
GMP
Est. Listing
₹35
at current GMP
Subscribed
1.43x
overall
Open
29 Sep 2025
Close
1 Oct 2025
Allotment
3 Oct 2025
Refund
4 Oct 2025
Demat Credit
5 Oct 2025
Listing
7 Oct 2025
Designated Registrar: Kfin Technologies Limited
Allotment Date
3 Oct 2025
Basis finalization
Refunds Initiate
4 Oct 2025
Mandate release
Demat Credit
5 Oct 2025
Shares in demat
Listing Debut
7 Oct 2025
Trading begins
Vijaypd Ceutical Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹19.25 Crores. The shares are offered at a price band of ₹35 to ₹35 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 4000 shares (approx. ₹1,40,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-10-05, while un-allotted funds or UPI block mandates will be released on 2025-10-04.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.